Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 2,085 | 1,806 | 2,874 | 2,684 | 2,350 |
| Gross Profit | 2,085 | 1,806 | 2,874 | 2,684 | 2,350 |
| Operating Expenses | 22,964 | 21,808 | 19,971 | 17,333 | 18,198 |
| Operating Income | -20,879 | -20,002 | -17,097 | -14,649 | -15,848 |
| Interest Expense | 32 | 586 | 589 | 589 | 587 |
| Other Income | 86 | 45 | -105 | 128 | -70 |
| Pre-tax Income | -20,825 | -20,543 | -17,791 | -15,110 | -16,505 |
| Net Income Continuous | -20,825 | -20,543 | -17,791 | -15,110 | -16,505 |
| Net Income | $-20,825 | $-20,543 | $-17,791 | $-15,110 | $-16,505 |
| EPS Basic Total Ops | -1.10 | -1.10 | -1.00 | -0.90 | -1.10 |
| EPS Basic Continuous Ops | -1.14 | -1.14 | -1.00 | -0.90 | -1.06 |
| EPS Diluted Total Ops | -1.10 | -1.10 | -1.00 | -0.90 | -1.10 |
| EPS Diluted Continuous Ops | -1.14 | -1.14 | -1.00 | -0.90 | -1.06 |
| EBITDA(a) | $-20,280 | $-19,365 | $-16,459 | $-14,015 | $-15,252 |